Literature DB >> 19435904

Complex oncogenic translocations with gene amplification are initiated by specific DNA breaks in lymphocytes.

Sarah M Wright1, Yong H Woo, Travis L Alley, Bobbi-Jo Shirley, Ellen C Akeson, Kathy J Snow, Sarah A Maas, Rachel L Elwell, Oded Foreman, Kevin D Mills.   

Abstract

Chromosomal instability is a hallmark of many tumor types. Complex chromosomal rearrangements with associated gene amplification, known as complicons, characterize many hematologic and solid cancers. Whereas chromosomal aberrations, including complicons, are useful diagnostic and prognostic cancer markers, their molecular origins are not known. Although accumulating evidence has implicated DNA double-strand break repair in suppression of oncogenic genome instability, the genomic elements required for chromosome rearrangements, especially complex lesions, have not been elucidated. Using a mouse model of B-lineage lymphoma, characterized by complicon formation involving the immunoglobulin heavy chain (Igh) locus and the c-myc oncogene, we have now investigated the requirement for specific genomic segments as donors for complex rearrangements. We now show that specific DNA double-strand breaks, occurring within a narrow segment of Igh, are necessary to initiate complicon formation. By contrast, neither specific DNA breaks nor the powerful intronic enhancer Emu are required for complicon-independent oncogenesis. This study is the first to delineate mechanisms of complex versus simple instability and the first to identify specific chromosomal elements required for complex chromosomal aberrations. These findings will illuminate genomic cancer susceptibility and risk factors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19435904      PMCID: PMC2724672          DOI: 10.1158/0008-5472.CAN-08-4515

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  34 in total

Review 1.  V(D)J recombination: site-specific cleavage and repair.

Authors:  D R Kim; S J Park; M A Oettinger
Journal:  Mol Cells       Date:  2000-08-31       Impact factor: 5.034

2.  V(D)J recombinase binding and cleavage of cryptic recombination signal sequences identified from lymphoid malignancies.

Authors:  Ming Zhang; Patrick C Swanson
Journal:  J Biol Chem       Date:  2008-01-09       Impact factor: 5.157

3.  Requirement for enhancer specificity in immunoglobulin heavy chain locus regulation.

Authors:  Igor I Kuzin; Ludmila Bagaeva; Faith M Young; Andrea Bottaro
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

4.  Mitotic chromosome preparations from mouse cells for karyotyping.

Authors:  E C Akeson; M T Davisson
Journal:  Curr Protoc Hum Genet       Date:  2001-05

5.  The 12/23 rule is enforced at the cleavage step of V(D)J recombination in vivo.

Authors:  S B Steen; L Gomelsky; D B Roth
Journal:  Genes Cells       Date:  1996-06       Impact factor: 1.891

6.  Up-regulation of fibroblast growth factor 3 is associated with tumor metastasis and recurrence in human hepatocellular carcinoma.

Authors:  Liang Hu; Jonathan S T Sham; Dan Xie; Jian-Ming Wen; Wei-Sheng Wang; Yi Wang; Xin-Yuan Guan
Journal:  Cancer Lett       Date:  2007-01-09       Impact factor: 8.679

7.  Differential requirements for cis and trans V(D)J cleavage: effects of substrate length.

Authors:  L E Huye; D B Roth
Journal:  Nucleic Acids Res       Date:  2000-12-15       Impact factor: 16.971

8.  In a model of immunoglobulin heavy-chain (IGH)/MYC translocation, the Igh 3' regulatory region induces MYC expression at the immature stage of B cell development.

Authors:  Yi Yan; Sung Sup Park; Siegfried Janz; Laurel A Eckhardt
Journal:  Genes Chromosomes Cancer       Date:  2007-10       Impact factor: 5.006

9.  Lymphocyte-specific compensation for XLF/cernunnos end-joining functions in V(D)J recombination.

Authors:  Gang Li; Frederick W Alt; Hwei-Ling Cheng; James W Brush; Peter H Goff; Mike M Murphy; Sonia Franco; Yu Zhang; Shan Zha
Journal:  Mol Cell       Date:  2008-09-05       Impact factor: 17.970

10.  Multiple, conserved cryptic recombination signals in VH gene segments: detection of cleavage products only in pro B cells.

Authors:  Marco Davila; Feifei Liu; Lindsay G Cowell; Anne E Lieberman; Emily Heikamp; Anjali Patel; Garnett Kelsoe
Journal:  J Exp Med       Date:  2007-12-03       Impact factor: 14.307

View more
  4 in total

1.  Nuclear positioning, higher-order folding, and gene expression of Mmu15 sequences are refractory to chromosomal translocation.

Authors:  Kathy J Snow; Sarah M Wright; Yong Woo; Laura C Titus; Kevin D Mills; Lindsay S Shopland
Journal:  Chromosoma       Date:  2010-08-12       Impact factor: 4.316

2.  A hypomorphic Artemis human disease allele causes aberrant chromosomal rearrangements and tumorigenesis.

Authors:  Cheryl Jacobs; Ying Huang; Tehmina Masud; William Lu; Gerwin Westfield; William Giblin; JoAnn M Sekiguchi
Journal:  Hum Mol Genet       Date:  2010-12-08       Impact factor: 6.150

3.  Mitotic defects lead to pervasive aneuploidy and accompany loss of RB1 activity in mouse LmnaDhe dermal fibroblasts.

Authors:  C Herbert Pratt; Michelle Curtain; Leah Rae Donahue; Lindsay S Shopland
Journal:  PLoS One       Date:  2011-03-25       Impact factor: 3.240

4.  The lipogenic LXR-SREBF1 signaling pathway controls cancer cell DNA repair and apoptosis and is a vulnerable point of malignant tumors for cancer therapy.

Authors:  Bo Yang; Bin Zhang; Zhifei Cao; Xingdong Xu; Zihe Huo; Pan Zhang; Shufen Xiang; Zhe Zhao; Chunping Lv; Mei Meng; Gaochuan Zhang; Liang Dong; Shucheng Shi; Lan Yang; Quansheng Zhou
Journal:  Cell Death Differ       Date:  2020-03-06       Impact factor: 15.828

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.